KUALA LUMPUR -- Malaysian sovereign wealth fund Khazanah Nasional Bhd has ceased to be a substantial shareholder in genetics screening company Malaysian Genomics Resource Centre Bhd (MGRC) after a recent share sale.
The development comes after Khazanah sold 12 million shares, an 11.59% stake, through indirect subsidiary Synamatix Sdn Bhd, according to a bourse filing on May 15.